EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies

Evan M Cale, Chen-Hsiang Shen, Adam S Olia, Nathan A Radakovich, Reda Rawi, Yongping Yang, David R Ambrozak, Anthony K Bennici, Gwo-Yu Chuang, Emma D Crooks, Jefferson I Driscoll, Bob C Lin und 17 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.115010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Evan M Cale und 28 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: HIV Envelope Protein gp120, Polysaccharides, HIV-1, Antibodies, Neutralizing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV Envelope Protein gp120PolysaccharidesHIV-1Antibodies, NeutralizingHIV Envelope Protein gp41HumansHIV AntibodiesBroadly Neutralizing AntibodiesCryoelectron Microscopy

Stichwörter der Autor:innen

35O22CP: ImmunologyCP: Molecular biologyHIV-1 envelope trimerN90broadly neutralizing antibodyglycanmultidonor antibody classsubunit interface

Substanzen

HIV Envelope Protein gp120PolysaccharidesAntibodies, NeutralizingHIV Envelope Protein gp41HIV AntibodiesBroadly Neutralizing Antibodies

Autor:innen und Institutionen

  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • San Diego Biomedical Research Institute, San Diego, CA 92121, USA.
  • Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: nicole.doriarose@nih.gov.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicia…
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; ModeX Therapeutics, Weston, MA 02493, USA.

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Cale, E. M., Shen, C. H., Olia, A. S., Radakovich, N. A., Rawi, R., Yang, Y., Ambrozak, D. R., Bennici, A. K., Chuang, G. Y., Crooks, E. D., Driscoll, J. I., Lin, B. C., Louder, M. K., Madden, P. J., Messina, M. A., Osawa, K., Stewart-Jones, G. B. E., Verardi, R., Vrakas, Z., …, & Gorman, J. (2024). A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115010

Vancouver

Cale EM, Shen CH, Olia AS, Radakovich NA, Rawi R, Yang Y, et al. A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports. 2024. doi:10.1016/j.celrep.2024.115010

BibTeX
@article{Cale2024,
  author = {Cale, Evan M and Shen, Chen-Hsiang and Olia, Adam S and Radakovich, Nathan A and Rawi, Reda and Yang, Yongping and Ambrozak, David R and Bennici, Anthony K and Chuang, Gwo-Yu and Crooks, Emma D and Driscoll, Jefferson I and Lin, Bob C and Louder, Mark K and Madden, Patrick J and Messina, Michael A and Osawa, Keiko and Stewart-Jones, Guillaume B E and Verardi, Raffaello and Vrakas, Zoe and Xie, Danielle and Zhang, Baoshan and Binley, James M and Connors, Mark and Koup, Richard A and Pierson, Theodore C and Doria-Rose, Nicole A and Kwong, Peter D and Mascola, John R and Gorman, Jason},
  title = {A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.115010}
}
Kostenlos starten →